FDA Drug Recalls

Recalls / Class III

Class IIID-0201-2021

Product

Morphine Sulfate 3 mg/3 mL in 0.9% Sodium Chloride (1mg/mL) CII, Rx Only, 3 ml Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004010025

Affected lot / code info
Lot # 1220023452, BUD 2/7/2021

Why it was recalled

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Recalling firm

Firm
SCA Pharmaceuticals
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
755 Rainbow Rd Ste B, Windsor, Connecticut 06095-1024

Distribution

Quantity
751 syringes
Distribution pattern
Product was distributed to hospitals nationwide.

Timeline

Recall initiated
2020-12-17
FDA classified
2021-01-07
Posted by FDA
2021-01-13
Terminated
2021-11-02
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0201-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.